PCR112 Expected Pricing and Access Hurdles in the US for Novel Rheumatoid Arthritis Therapies
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.2047
https://www.valueinhealthjournal.com/article/S1098-3015(22)04252-8/fulltext
Title :
PCR112 Expected Pricing and Access Hurdles in the US for Novel Rheumatoid Arthritis Therapies
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04252-8&doi=10.1016/j.jval.2022.09.2047
First page :
Section Title :
Open access? :
No
Section Order :
11605